Bone Biologics Corp Stock Price Prediction
| BBLG Stock | USD 1.54 0.06 3.75% |
Oversold Vs Overbought
31
Oversold | Overbought |
Bone Biologics Corp stock price prediction is an act of determining the future value of Bone Biologics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Bone Biologics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bone Biologics and does not consider all of the tangible or intangible factors available from Bone Biologics' fundamental data. We analyze noise-free headlines and recent hype associated with Bone Biologics Corp, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Bone Biologics' stock price prediction:EPS Estimate Next Quarter (7.60) | EPS Estimate Current Year (30.13) | EPS Estimate Next Year (31.56) | Wall Street Target Price 19.5 | EPS Estimate Current Quarter (5.60) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Bone Biologics based on different types of headlines from major news networks to social media. The Bone stock price prediction module provides an analysis of price elasticity to changes in media outlook on Bone Biologics over a specific investment horizon. Using Bone Biologics hype-based prediction, you can estimate the value of Bone Biologics Corp from the perspective of Bone Biologics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Bone Biologics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Bone Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying Bone because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bone Biologics after-hype prediction price | USD 1.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bone |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bone Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bone Biologics After-Hype Price Prediction Density Analysis
As far as predicting the price of Bone Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bone Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bone Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bone Biologics Estimiated After-Hype Price Volatility
In the context of predicting Bone Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bone Biologics' historical news coverage. Bone Biologics' after-hype downside and upside margins for the prediction period are 0.06 and 8.97, respectively. We have considered Bone Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bone Biologics is moderately volatile at this time. Analysis and calculation of next after-hype price of Bone Biologics Corp is based on 3 months time horizon.
Bone Biologics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bone Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bone Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bone Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.01 | 7.83 | 0.46 | 0.02 | 6 Events / Month | 1 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.54 | 1.14 | 28.75 |
|
Bone Biologics Hype Timeline
Bone Biologics Corp is currently traded for 1.54. The entity has historical hype elasticity of -0.46, and average elasticity to hype of competition of -0.02. Bone is expected to decline in value after the next headline, with the price expected to drop to 1.14. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -28.75%, whereas the daily expected return is currently at -1.01%. The volatility of related hype on Bone Biologics is about 52200.0%, with the expected price after the next announcement by competition of 1.52. The company has price-to-book (P/B) ratio of 0.51. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bone Biologics Corp recorded a loss per share of 34.01. The entity last dividend was issued on the 24th of July 2018. The firm had 1:8 split on the 20th of December 2023. Given the investment horizon of 90 days the next expected press release will be in about 6 days. Check out Bone Biologics Basic Forecasting Models to cross-verify your projections.Bone Biologics Related Hype Analysis
Having access to credible news sources related to Bone Biologics' direct competition is more important than ever and may enhance your ability to predict Bone Biologics' future price movements. Getting to know how Bone Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bone Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| THMO | Thermogenesis Holdings | (0.05) | 2 per month | 5.95 | 0.13 | 18.89 | (10.14) | 54.53 | |
| MOTS | Motus GI Holdings | 0.02 | 8 per month | 0.00 | (0.23) | 6.56 | (28.18) | 120.11 |
Bone Biologics Additional Predictive Modules
Most predictive techniques to examine Bone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bone using various technical indicators. When you analyze Bone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bone Biologics Predictive Indicators
The successful prediction of Bone Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bone Biologics Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bone Biologics based on analysis of Bone Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bone Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bone Biologics's related companies. | 2010 | 2023 | 2024 (projected) | Payables Turnover | 7.33 | 0.001341 | 0.001274 | Days Of Inventory On Hand | 409.11 | 368.2 | 327.29 |
Story Coverage note for Bone Biologics
The number of cover stories for Bone Biologics depends on current market conditions and Bone Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bone Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bone Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Bone Biologics Short Properties
Bone Biologics' future price predictability will typically decrease when Bone Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bone Biologics Corp often depends not only on the future outlook of the potential Bone Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bone Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 263.1 K | |
| Cash And Short Term Investments | 3 M |
Check out Bone Biologics Basic Forecasting Models to cross-verify your projections. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.01) | Return On Assets (0.96) | Return On Equity (2.02) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.